Figure 2: Optimized structures of A) Cisplatin. Left: gas-phase optimized geometry and Right: Solvent-phase optimized geometry. B) Oxaliplatin (transl_ 1R_2R, trans-d_1S_2S and cis_1R_2S conformers of oxaliplatin in that order from left to right); C) BNP3029 (all gauche, all trans, trans/gauche forms of cyano ligands on BNP3029 in that order from left to right). All distances are in Angstroms (Å) and angles are in degrees.